Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) Income from Non-Controlling Interests (2017 - 2025)

National Healthcare (NHC) has disclosed Income from Non-Controlling Interests for 9 consecutive years, with $391000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Income from Non-Controlling Interests rose 49.24% year-over-year to $391000.0, compared with a TTM value of $335000.0 through Jun 2025, up 166.73%, and an annual FY2025 reading of $2.6 million, up 1529.56% over the prior year.
  • Income from Non-Controlling Interests was $391000.0 for Q2 2025 at National Healthcare, up from $85000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $391000.0 in Q2 2025 and bottomed at -$1.0 million in Q2 2022.
  • Average Income from Non-Controlling Interests over 5 years is -$145000.0, with a median of -$7000.0 recorded in 2024.
  • The sharpest move saw Income from Non-Controlling Interests surged 254.48% in 2021, then tumbled 476.33% in 2022.
  • Year by year, Income from Non-Controlling Interests stood at $207000.0 in 2021, then crashed by 476.33% to -$779000.0 in 2022, then skyrocketed by 53.27% to -$364000.0 in 2023, then soared by 85.71% to -$52000.0 in 2024, then surged by 851.92% to $391000.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for NHC at $391000.0 in Q2 2025, $85000.0 in Q1 2025, and -$52000.0 in Q4 2024.